SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-025666
Filing Date
2022-11-23
Accepted
2022-11-23 16:09:07
Documents
12
Period of Report
2022-11-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K flgt-20221118.htm   iXBRL 8-K 49888
  Complete submission text file 0000950170-22-025666.txt   163618

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flgt-20221118.xsd EX-101.SCH 2482
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flgt-20221118_pre.xml EX-101.PRE 10506
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flgt-20221118_lab.xml EX-101.LAB 12798
6 EXTRACTED XBRL INSTANCE DOCUMENT flgt-20221118_htm.xml XML 4530
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37894 | Film No.: 221416420
SIC: 8071 Services-Medical Laboratories
Industrial Applications and Services